The FXN gene makes frataxin, a protein that helps cells manage iron and produce energy, especially in nerves, muscles, and the heart. When this gene does not work well, cells become stressed and this can cause Friedreich ataxia. People with Friedreich ataxia often notice worsening balance and walking, weakness, and changes in feeling in the feet and legs, and some also develop heart problems or diabetes. FXN is mainly known because it is the gene linked to Friedreich ataxia.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, which are the working parts of cells. Others mainly guide when, where, and how strongly certain processes take place. Together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, and medications. To explore this topic more deeply, you can find more in the LearnHub.
Overview
FXNGene function
What if the gene works
The FXN gene helps your cells make frataxin, a protein in mitochondria, the parts that produce energy. Frataxin supports iron handling and helps build cell parts that many enzymes need to work normally.
Risk
What if the gene does not work
When the FXN gene works poorly, people can develop Friedreich ataxia, affecting balance, coordination, sensation, and often the heart. Milder or more severe variants can influence when symptoms begin and how strongly movement or heart problems appear.
Treatment
What does that mean for your treatment
A pathogenic variant in the FXN gene can support use of disease-specific treatment for Friedreich ataxia, including omaveloxolone where approved. Drug choice is usually not based on the exact FXN variant, but symptoms such as heart involvement or diabetes can shape supportive medicines and monitoring.
Conditions associated with FXN
Gene function
What if the gene works
Your cells need a steady energy supply to move muscles, send nerve signals, and carry out routine repair. The FXN gene helps mitochondria, the parts of cells that make most of this energy, manage iron and keep key enzymes working. Knowing what the FXN gene does in the body helps explain how cells stay powered through everyday demands.
The FXN gene helps mitochondria handle iron in a controlled way. This keeps enough iron available for cell work without letting it collect in the wrong place.
Its protein helps make iron-sulfur clusters (tiny iron-based parts that many enzymes need). These clusters allow important cell proteins to do routine jobs linked to energy use and cell upkeep.
By supporting mitochondria, the FXN gene helps cells keep energy production steady. This is especially important in tissues that work hard all day, such as muscles, the heart, and the nervous system.
What is a variant?
Common throughout the population, genetic variants are small changes in the DNA sequence of a gene. They help explain normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect at all and simply reflect natural genetic variation. In some situations, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most changes linked to Friedreich ataxia in the FXN gene lower the amount of frataxin a cell can make. A common change is a GAA repeat expansion that interferes with gene reading, so cells produce much less protein. Other variants can make frataxin unstable or less able to work, which shows how variants influence the FXN gene's function in cells. These DNA changes can range from milder to more severe, and lower frataxin levels often mean earlier Friedreich ataxia.
How variants are linked to conditions
Pathogenic variants in the FXN gene cause Friedreich ataxia, the main well-established condition linked to this gene. FXN gene variants and Friedreich ataxia are closely connected in medical genetics, especially when a person inherits disease-causing variants from both parents. People with this condition often develop problems with balance and walking, and some also have heart involvement or diabetes.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most have no direct impact on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FXN, risk is mainly set by whether someone inherits harmful changes in both copies of the gene. In people living with Friedreich ataxia, larger repeat changes in FXN are often linked with earlier symptoms and sometimes more severe disease. There is not enough evidence to say lifestyle changes lower the chance of developing it, but ongoing checkups can help find complications early.
Inheritance of FXN variants
Variants in the FXN gene linked to Friedreich ataxia are inherited in an autosomal recessive pattern. This means a person usually inherits one changed copy of the FXN gene from each parent. If both parents carry one FXN variant, each pregnancy has a 25% chance of resulting in a child with Friedreich ataxia, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither changed copy. In practical terms, FXN gene inheritance usually affects brothers and sisters in the same family rather than passing directly from an affected parent to every child.
What does my FXN result mean for my family?
For families with an FXN result linked to Friedreich ataxia, close relatives may also carry the same gene change, even if they feel completely well. Brothers and sisters may be affected or be carriers, and other blood relatives may also carry it. This is usually a recessive condition, so family implications often center on whether relatives are carriers and whether both parents passed on an FXN change.
Genetic information
Genetic testing
How you find out about variants
FXN genetic testing for Friedreich ataxia usually uses a blood or saliva sample. A lab checks the DNA for the common FXN repeat expansion and for other variants in the FXN gene. Results can show whether you carry one or two changed copies, which helps clarify diagnosis or carrier status.
When should I consider getting a genetic test?
Testing for the FXN gene can be worth discussing if you or your child has signs of Friedreich ataxia, such as worsening balance and walking problems, slurred speech, or unexplained heart trouble, especially when symptoms start at a young age. It can also help if Friedreich ataxia runs in the family or a relative is known to have an FXN gene change.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they explain varies with the condition and the specific kind of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when viewed together with other parts of care. In other situations, a genetic finding may give a clear explanation. In areas like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, which can change how much of it reaches the body and brain. This is one reason the same treatment may work well for one person but less well for another, or may cause more side effects in some people. These differences are common and can influence both how effective a medicine is and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently in different people. For many drugs, genes can influence how strongly a medicine works or how the body processes it. This information can support more informed, more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the FXN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are used, so any concerns about symptoms, treatment, or side effects are best discussed with your doctor.
History
Friedreich ataxia was first described in the 1860s by the German physician Nikolaus Friedreich, long before anyone knew the responsible gene. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition became a major focus of inherited neurologic research. In 1996, researchers identified changes in the FXN gene as the cause, a landmark finding that explained why the condition runs in families. They also showed that many affected people carry an expanded GAA repeat, a repeated stretch of DNA that had gone unnoticed for years. From these first observations, research expanded steadily. This discovery gave families clearer answers and shaped modern diagnosis, carrier testing, and research into treatment.